# FDA Inspection 894333 - ACS Dobfar S.p.A. #4 - September 12, 2014

Source: https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa-4/0adcb8c7-e823-43a4-930a-4d6ee1453e84
Source feed: FDA_Inspections

> FDA Inspection 894333 for ACS Dobfar S.p.A. #4 on September 12, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 894333
- Company Name: ACS Dobfar S.p.A. #4
- Inspection Date: 2014-09-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1286310 - 2023-05-26](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa-4/e074938e-feda-45f4-b426-6dc8b5493708)
- [FDA Inspection 1095522 - 2018-10-26](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa-4/f38521cb-43cb-4258-91f3-ba29ed9fd2e2)
- [FDA Inspection 722608 - 2010-12-16](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa-4/326175d0-2318-4416-aac1-30f53514d183)

Company: https://www.keypedia.com/companies/acs-dobfar-spa-4/5bda0cf8-779f-477e-a449-9d3f8fdd0e1f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c